BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 24399614)

  • 1. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
    Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
    Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Caffeine versus theophylline for apnea in preterm infants.
    Henderson-Smart DJ; Steer PA
    Cochrane Database Syst Rev; 2010 Jan; (1):CD000273. PubMed ID: 20091506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
    Skouroliakou M; Bacopoulou F; Markantonis SL
    J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prophylactic methylxanthine for prevention of apnoea in preterm infants.
    Henderson-Smart DJ; De Paoli AG
    Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD000432. PubMed ID: 21154344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine citrate: a review of its use in apnoea of prematurity.
    Comer AM; Perry CM; Figgitt DP
    Paediatr Drugs; 2001; 3(1):61-79. PubMed ID: 11220405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current options in the management of apnea of prematurity.
    Bhatia J
    Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine versus theophylline for apnea in preterm infants.
    Steer PA; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2000; (2):CD000273. PubMed ID: 10796190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylxanthine treatment for apnoea in preterm infants.
    Henderson-Smart DJ; De Paoli AG
    Cochrane Database Syst Rev; 2010 Dec; (12):CD000140. PubMed ID: 21154343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
    Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
    JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
    Mohammed S; Nour I; Shabaan AE; Shouman B; Abdel-Hady H; Nasef N
    Eur J Pediatr; 2015 Jul; 174(7):949-56. PubMed ID: 25644724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylxanthines in apnea of prematurity.
    Aranda JV; Turmen T
    Clin Perinatol; 1979 Mar; 6(1):87-108. PubMed ID: 383366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National and international guidelines for neonatal caffeine use: Are they evidenced-based?
    Eichenwald EC
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101177. PubMed ID: 33214064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine citrate therapy for apnea of prematurity.
    Johnson PJ
    Neonatal Netw; 2011; 30(6):408-12. PubMed ID: 22052121
    [No Abstract]   [Full Text] [Related]  

  • 14. Caffeine citrate: when and for how long. A literature review.
    Picone S; Bedetta M; Paolillo P
    J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():11-4. PubMed ID: 23016611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. When to start and stop caffeine and why respiratory status matters.
    Davis PG
    Semin Fetal Neonatal Med; 2020 Dec; 25(6):101175. PubMed ID: 33144042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates.
    Larsen PB; Brendstrup L; Skov L; Flachs H
    Acta Paediatr; 1995 Apr; 84(4):360-4. PubMed ID: 7795341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylxanthine treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000140. PubMed ID: 10796304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term effects of caffeine therapy for apnea of prematurity.
    Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
    N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylxanthine treatment for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2001; (3):CD000140. PubMed ID: 11686952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Caffeine citrate utilization for treatment of apnea in French neonatal units].
    Ducrocq S; Biran-Mucignat V; Lebas F; Baudon JJ; Gold F
    Arch Pediatr; 2006 Oct; 13(10):1305-8. PubMed ID: 16872813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.